drugset / Trial / NCT02820714

A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

NCT02820714 ↗

Phase 2 Completed 16 enrolled Braintree Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate BLI801 laxative in adults experiencing non-idiopathic constipation.

Timeline

Start
2016-02
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI801 Unknown — Oral

Indications